LIVE! Tobacco Cessation and Lung Cancer Screening Brief Intervention Ask, Advise, Refer Workshop
Online Webinar

Now Available in Webinar Format

The American Lung Association's Ask, Advise, Refer to Quit Don’t Switch (“Ask, Advise, Refer”) training is now being offered as a live, interactive, virtual workshop. This training is ideal for frontline healthcare professionals, patient navigators, nurses, nurse practitioners, respiratory therapists, clinical support staff, community health workers and tobacco treatment specialists. The curriculum is based on the CDC’s AskAdviseRefer (AAR) model and utilizes updated tools and strategies for facilitating the routine assessment of tobacco use status and lung cancer risk and low-dose CT scan eligibility among all patients, delivery of brief advice to quit tobacco use, referral to a clinician for a shared-decision making appointment for those identified as high risk for lung cancer and referral of tobacco users to evidence-based cessation programs such as Freedom From SmokingŪ.

We are proud to provide credits to those who complete this virtual training which is accredited for one hour of Continuing Medical Education (CME) by Rehoboth McKinley Christian Health Care Services and one Continuing Education Unit (CEU) by the American Association of Respiratory Care.

This event will be held via Microsoft Teams on November 10 at 1:00 PM (CT). It will require a secondary registration through the virtual platform once you have signed up on this website. To register, please click the Registration button at the top of this page. A follow up email will then be generated and will contain the link and next steps to access the workshop on the day of the training.

Learning Objectives:

  • Participants will be able to describe the brief intervention process, along with strategies for countering false e-cigarette marketing claims in guiding patients towards quitting tobacco products, not switching to e-cigarette devices.
  • Participants will be able to establish an evidence-based, proven-effective, comprehensive tobacco treatment plan with their patients that includes a combination of both counseling plus FDA-approved cessation medication to aid in their quit attempts.
  • Participants will learn about low-dose CT scans for lung cancer (including how screening is key to early detection) and be able to administer a brief lung cancer risk assessment with all patients and clients to determine their eligibility, as well as subsequently refer qualifying individuals to a clinician for a shared decision-making appointment.
Tobacco Cessation and Lung Cancer Screening Integration

Smoking contributes to 80% of lung cancer deaths in women and 90% of lung cancer deaths in men. As such, smoking cessation is a critical component of any comprehensive approach to saving lives from lung cancer and protecting lung health yet four out of every nine adult cigarette smokers who saw a health professional during the past year did not receive advice to quit. Lung cancer screening using low-dose CT scans helps diagnose lung cancer at earlier stages of the disease when there are better opportunities to treat it; in fact, screening among those at high risk of developing lung cancer can reduce mortality by up to 20%. Still, lung cancer screening is underutilized—especially in historically underserved communities—with only 6% of those currently eligible getting screened nationwide. The American Lung Association, from coast to coast, strives to change lives one breath at a time and an integrated approach to conducting brief tobacco interventions and lung cancer risk assessments among patients at every encounter through your participation in our Ask, Advise, Refer workshop will make a lasting impact on those communities you serve.

To learn more about tobacco cessation and lung cancer screening integration we encourage you to download our guide.

Contact us anytime and check back often for updates on our Ask, Advise, Refer Workshop!

Time: 1:00 PM - 2:30 PM

We're sorry, the deadline for registering for this event has passed.